Robert Vink

Prof Robert Vink

School of Architecture and Built Environment

College of Creative Arts, Design and Humanities

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

Available For Media Comment.


I am a neuroscientist who specialises in acute brain injury research. After completing my BSc (Hons) and PhD at Griffith University in Brisbane (Aust), I was awarded a Sandoz Postdoctoral Neuroscience Fellowship in the Neurology Department at the University of California, San Francisco (UCSF) where at the end of that fellowship I was appointed as an Assistant Research Professor. I was then fortunate to be awarded a Queen Elizabeth II Fellowship (Aust) which allowed me to return to Australia and undertake research at James Cook University in Townsville, North Queensland, focusing on magnetic resonance studies of traumatic brain injury.  At the conclusion of my fellowship, I was appointed as an academic staff member and over time became an Associate Professor and Head of Department of Physiology and Pharmacology. A period of sabbatical research as an Adjunct Professor at Georgetown University, Washington DC, inspired me to move to the University of Adelaide in 2001 where I again focused on research in the Department of Pathology. I was subsequently appointed to be the NRF Chair of Neurosurgical Research and the Head of the School of Medical Sciences. In 2014, I took the opportunity to join the University of South Australia as the Pro Vice-Chancellor of Health Sciences and following my retirement from academia in 2019, was honoured with an Emeritus Professor position.
My research has always focused on identifying secondary injury factors following CNS injury, and the associated development of novel pharmacotherapies that improve functional outcome. During my early career, most of my time was spent characterising the role of magnesium in traumatic brain injury. In the second half of my career, my research time was spent characterising neurogenic inflammation in acute and chronic brain injury, particularly its role in brain oedema, the development of elevated intracranial pressure and in repeated concussion / chronic traumatic encephalopathy (CTE). A couple of patents in this area have been licensed to pharmaceutical industry and are happily progressing through clinical development (phase II trials have commenced).
Along the way, there have been a few honours and awards including being the invited Japanese Society for Neurotraumatology Visiting Professor in 2001, and presenting the Jamieson Memorial Lecture and receiving the associated medal at the Neurosurgical Society of Australasia annual meeting in 2009. In 2012, the University of Adelaide awarded me a DSc for my international contributions to neurotrauma research. The Australasian Neuroscience Society and the Neurosurgical Society of Australasia gave me the honour of presenting the Eccles Lecture at their annual meetings in 2015, where the Australasian Neuroscience Society also awarded me their Society medal. Later that year, I was inducted as a fellow of the Australian Academy of Health and Medical Sciences. In 2018 I was made a Member of the Order of Australia (AM).
In terms of service to organisations, I am a member of the Board of Officers for the International Neurotrauma Society and a regular member of the scientific committee of the International Society for Development of Research on Magnesium. Nationally, I am the Chair of the Board of Connectivity: Traumatic Brain Injury Australia and am the Co-Chair of the $50 M Federal MRFF Traumatic Brain Injury Mission. 

Year Citation
2024 Vink, R. (2024). Preface. Substance P from Pain to Cancer, xxv-xxvi.
DOI
2024 Vink, R., & Nimmo, A. (2024). Identification of an Intravenous Injectable NK1 Receptor Antagonist for Use in Traumatic Brain Injury. International Journal of Molecular Sciences, 25(6), 18 pages.
DOI Scopus3 WoS2 Europe PMC2
2024 Sorby-Adams, A. J., Marian, O. C., Bilecki, I. M., Elms, L. E., Yassi, N., Hood, R. J., . . . Turner, R. J. (2024). NK1 tachykinin receptor antagonist treatment reduces cerebral edema and intracranial pressure in an ovine model of ischemic stroke. Journal of Cerebral Blood Flow and Metabolism, 44(10), 1759-1773.
DOI Scopus4 WoS1 Europe PMC1
2024 Byard, R. W., & Vink, R. (2024). Does citing early SIDS research skew contemporary conclusions?. Forensic Science, Medicine, and Pathology, 21(2), 981-983.
DOI
2024 Tiemensma, M., Byard, R. W., Vink, R., Affleck, A. J., Blumbergs, P., & Buckland, M. E. (2024). Chronic traumatic encephalopathy (CTE) in the context of longstanding intimate partner violence. Acta Neuropathologica, 148(1), 1-3.
DOI Scopus13 WoS10 Europe PMC10
2023 Byard, R., Tiemensma, M., Buckland, M. E., & Vink, R. (2023). Chronic traumatic encephalopathy (CTE)—features and forensic considerations. Forensic Science Medicine and Pathology, 19(4), 620-624.
DOI Scopus13 WoS11 Europe PMC6
2022 Vink, R., & Corrigan, F. (2022). Chronic traumatic encephalopathy: Genes load the gun and repeated concussion pulls the trigger. Neural Regeneration Research, 17(9), 1963-1964.
DOI Scopus1
2022 Shaukat, Z., Byard, R. W., Vink, R., Hussain, R., Ricos, M. G., & Dibbens, L. M. (2022). Investigating genetic variants in microRNA regulators of Neurokinin-1 receptor in sudden infant death syndrome. Acta Paediatrica, 112(2), 4 pages.
DOI Scopus1 Europe PMC1
2021 Corrigan, F., Cernak, I., McAteer, K., Hellewell, S. C., Rosenfeld, J. V., Turner, R. J., & Vink, R. (2021). NK1 antagonists attenuate tau phosphorylation after blast and repeated concussive injury. Scientific Reports, 11(1), 1-9.
DOI Scopus18 WoS15 Europe PMC19
2021 Byard, R. W., & Vink, R. (2021). Does listing of individual contributions in “Mega-Authorship” papers always follow best practice guidelines?. Forensic Science, Medicine and Pathology, 17(4), 545-546.
DOI Scopus6 WoS6 Europe PMC4
2019 Stewart, W., Allinson, K., Al Sarraj, S., Bachmeier, C., Vink, R., & Smith, D. H. (2019). Primum non nocere: a call for balance when reporting on CTE. The lancet neurology, 18(3), 231-233.
DOI Scopus59 WoS50 Europe PMC36
2019 Agoston, D. V., Vink, R., Helmy, A., Risling, M., Nelson, D., & Prins, M. (2019). How to translate time: the temporal aspects of rodent and human pathobiological processes in traumatic brain injury. Journal of Neurotrauma, 36(11), 1724-1737.
DOI Scopus41 WoS36 Europe PMC36
2019 Sorby-Adams, A. J., Leonard, A., Elms, L. E., Marian, O. C., Hoving, J. W., Yassi, N., . . . Turner, R. J. (2019). Determining the temporal profile of intracranial pressure changes following transient stroke in an ovine model. Frontiers in Neuroscience, 13(00587), 587-1-587-16.
DOI Scopus13 WoS13 Europe PMC12
2019 Sorby-Adams, A. J., Leonard, A., Hoving, J. W., Yassi, N., Vink, R., Wells, A. J., & Turner, R. J. (2019). NK1-r antagonist treatment comparable to decompressive craniectomy in reducing intracranial pressure following stroke. Frontiers in Neuroscience, 13(00681), 681-1-681-12.
DOI Scopus14 WoS14 Europe PMC12
2018 Sorby-Adams, A., Vink, R., & Turner, R. (2018). Large animal models of stroke and traumatic brain injury as translational tools. American Journal of Physiology - Regulatory Integrative and Comparative Physiology, 315(2), 165-190.
DOI Scopus88 WoS83 Europe PMC74
2018 Bright, F., Vink, R., & Byard, R. (2018). Neuropathological Developments in Sudden Infant Death Syndrome. Pediatric and Developmental Pathology, 21(6), 515-521.
DOI Scopus18 WoS15 Europe PMC12
2018 Bright, F. M., Vink, R., & Byard, R. W. (2018). The potential role of substance P in brainstem homeostatic control in the pathogenesis of sudden infant death syndrome (SIDS). Neuropeptides, 70, 1-8.
DOI Scopus15 WoS8 Europe PMC10
2018 Byard, R., Donkin, J., & Vink, R. (2018). The Forensic Implications of Amphetamine Intoxication in Cases of Inflicted Blunt Craniocerebral Trauma. Journal of Forensic Sciences, 63(1), 151-153.
DOI Scopus10 WoS6 Europe PMC4
2018 Vink, R. (2018). Large animal models of traumatic brain injury. Journal of Neuroscience Research, 96(4), 527-535.
DOI Scopus121 WoS114 Europe PMC97
2018 Byard, R., Bright, F., & Vink, R. (2018). Why is a prone sleeping position dangerous for certain infants?. Forensic Science, Medicine, and Pathology, 14(1), 114-116.
DOI Scopus19 WoS13 Europe PMC8
2018 Bright, F., Byard, R., Vink, R., & Paterson, D. (2018). Normative distribution of substance P and its tachykinin neurokinin-1 receptor in the medullary serotonergic network of the human infant during postnatal development. Brain research bulletin, 137, 319-328.
DOI Scopus13 WoS9 Europe PMC9
2018 Plummer, S., Corrigan, F., Thornton, E., Woenig, J., Vink, R., Cappai, R., & Den Heuvel, C. (2018). The amyloid precursor protein derivative, APP96-110, is efficacious following intravenous administration after traumatic brain injury. PLoS ONE, 13(1), e0190449-1-e0190449-16.
DOI Scopus17 WoS15 Europe PMC12
2018 Vink, R. (2018). Reflections on 35 Years of Journal of Neurotrauma. Journal of Neurotrauma, 35(1), 13-14.
DOI
2017 Ameliorate, J. L., Ghabriel, M. N., & Vink, R. (2017). Magnesium enhances the beneficial effects of NK1 antagonist administration on blood-brain barrier permeability and motor outcome after traumatic brain injury. Magnesium research, 30(3), 88-97.
DOI Scopus12 WoS12 Europe PMC11
2017 Bright, F., Vink, R., Byard, R., Duncan, J., Krous, H., & Paterson, D. (2017). Abnormalities in substance P neurokinin-1 receptor binding in key brainstem nuclei in sudden infant death syndrome related to prematurity and sex. PloS One, 12(9), e0184958-1-e0184958-14.
DOI Scopus27 WoS21 Europe PMC19
2017 Bright, F., Byard, R., Vink, R., & Patersonv, D. (2017). Medullary serotonin neuron abnormalities in an Australian cohort of sudden infant death syndrome. Journal of Neuropathology and Experimental Neurology, 76(10), 864-873.
DOI Scopus28 WoS22 Europe PMC21
2017 Vink, R., Gabrielian, L., & Thornton, E. (2017). The role of substance P in secondary pathophysiology after traumatic brain injury. Frontiers in Neurology, 8(304), 304-1-304-8.
DOI Scopus56 WoS48 Europe PMC41
2017 Corrigan, F., Arulsamy, A., Collins-Praino, L., Holmes, J., & Vink, R. (2017). Toll like receptor 4 activation can be either detrimental or beneficial following mild repetitive traumatic brain injury depending on timing of activation. Brain, Behavior, and Immunity, 64(3), 124-139.
DOI Scopus41 WoS37 Europe PMC30
2017 Zhou, C., Vink, R., & Byard, R. (2017). Hyperosmolarity Induces Armanni-Ebstein-like Renal Tubular Epithelial Swelling and Cytoplasmic Vacuolization. Journal of Forensic Sciences, 62(1), 229-232.
DOI Scopus6 WoS8 Europe PMC8
2016 Katharesan, V., Lewis, M., Vink, R., & Johnson, I. (2016). Disparate changes in plasma and brainstem cytokine levels in adult and ageing rats associated with age-related changes in facial motor neuron number, snout muscle morphology, and exploratory behavior. Frontiers in Neurology, 7(191), 191-1-191-9.
DOI Scopus7 WoS7 Europe PMC5
2016 Vink, R. (2016). Magnesium in the CNS: recent advances and developments. Magnesium research, 29(3), 95-101.
DOI Scopus39 WoS36 Europe PMC21
2016 Busingye, D., Turner, R., & Vink, R. (2016). Combined magnesium/polyethylene glycol facilitates the neuroprotective effects of magnesium in traumatic brain injury at a reduced magnesium dose. CNS Neuroscience and Therapeutics, 22(10), 854-859.
DOI Scopus13 WoS12 Europe PMC8
2016 McAteer, K., Corrigan, F., Thornton, E., Turner, R., & Vink, R. (2016). Short and long term behavioral and pathological changes in a novel rodent model of repetitive mild traumatic brain Injury. PLOS ONE, 11(8), e0160220-1-e0160220-18.
DOI Scopus81 WoS81 Europe PMC74
2016 Loughran, S., Al Hossain, M., Bentvelzen, A., Elwood, M., Finnie, J., Horvat, J., . . . Croft, R. (2016). Bioelectromagnetics research within an Australian context: the Australian centre for electromagnetic bioeffects research (ACEBR). International Journal of Environmental Research and Public Health, 13(10), 1-14.
DOI Scopus5 WoS5 Europe PMC1
2016 Corrigan, F., Mander, K., Leonard, A., & Vink, R. (2016). Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation. Journal of Neuroinflammation, 13(1), 264-1-264-12.
DOI Scopus273 WoS255 Europe PMC211
2016 Shultz, S. R., McDonald, S. J., Vonder Haar, C., Meconi, A., Vink, R., van Donkelaar, P., . . . Christie, B. R. (2016). The potential for animal models to provide insight into mild traumatic brain injury: Translational challenges and strategies. Neuroscience and Biobehavioral Reviews, 76(Pt B), 19 pages.
DOI Scopus127 WoS127 Europe PMC106
2016 Leonard, A., Vink, R., & Byard, R. (2016). Brain Fluid Content Related to Body Position and Postmortem Interval - An Animal Model. Journal of Forensic Sciences, 61(3), 671-673.
DOI Scopus8 WoS4 Europe PMC4
2016 Corrigan, F., Vink, R., & Turner, R. J. (2016). Inflammation in acute CNS injury: a focus on the role of substance P. British Journal of Pharmacology, 173(4), 703-715.
DOI Scopus59 WoS50 Europe PMC49
2015 Newcombe, R., Finnie, J., Leonard, A., Manavis, J., Reilly, P., Vink, R., & Blumbergs, P. (2015). Apoptosis in human compressive myelopathy due to metastatic neoplasia. Spine, 40(8), E450-E457.
DOI Scopus1
2015 Leonard, A., & Vink, R. (2015). Reducing intrathecal pressure after traumatic spinal cord injury: a potential clinical target to promote tissue survival. Neural Regeneration Research, 10(3), 380-382.
DOI Scopus7 WoS6 Europe PMC6
2015 Wells, A., Vink, R., Helps, S., Knox, S., Blumbergs, P., & Turner, R. (2015). Elevated intracranial pressure and cerebral edema following permanent MCA occlusion in an ovine model. PLoS One, 10(6), e0130512-1-e0130512-20.
DOI Scopus21 WoS21 Europe PMC20
2015 Thornton, E., & Vink, R. (2015). Substance p and its tachykinin NK1 receptor: a novel neuroprotective target for parkinson’s disease. Neural Regeneration Research, 10(9), 1403-1405.
DOI Scopus16 WoS12 Europe PMC11
2015 Leonard, A., Thornton, E., & Vink, R. (2015). The relative contribution of edema and hemorrhage to raised intrathecal pressure following traumatic spinal cord injury. Journal of neurotrauma, 32(6), 397-402.
DOI Scopus57 WoS51 Europe PMC43
2015 Court-Kowalski, S., Finnie, J., Manavis, J., Blumbergs, P., Helps, S., & Vink, R. (2015). Effect of long-term (2 years) exposure of mouse brains to global system for mobile communication (GSM) radiofrequency fields on astrocytic immunoreactivity. Bioelectromagnetics, 36(3), 245-250.
DOI Scopus11 WoS9 Europe PMC8
2014 Leonard, A., Thornton, E., & Vink, R. (2014). NK1 receptor blockade is ineffective in improving outcome following a balloon compression model of spinal cord injury. PLoS One, 9(5), e98364-1-e98364-15.
DOI Scopus12 WoS10 Europe PMC8
2014 Leonard, A., Manavis, J., Blumbergs, P., & Vink, R. (2014). Changes in substance P and NK1 receptor immunohistochemistry following human spinal cord injury. Spinal Cord, 52(1), 17-23.
DOI Scopus12 WoS12 Europe PMC10
2014 Byard, R. W., & Vink, R. (2014). The law and the laboratory. Forensic Science, Medicine, and Pathology, 10(4), 481-482.
DOI Scopus1 WoS1
2014 Mander, K., Harford-Wright, E., Lewis, K., & Vink, R. (2014). Advancing drug therapy for brain tumours: a current review of the pro-inflammatory peptide substance P and its antagonists as anti-cancer agents. Recent Patents on CNS Drug Discovery, 9(2), 110-121.
DOI Scopus9 Europe PMC4
2014 Anderson, R. W. G., Sandoz, B., Dutschke, J. K., Finnie, J. W., Turner, R. J., Blumbergs, P. C., . . . Vink, R. (2014). Biomechanical studies in an ovine model of non-accidental head injury. Journal of Biomechanics, 47(11), 2578-2583.
DOI Scopus19 WoS16 Europe PMC15
2014 Harford-Wright, E., Lewis, K., Ghabriel, M., & Vink, R. (2014). Treatment with the NK1 antagonist emend reduces blood brain barrier dysfunction and edema formation in an experimental model of brain tumors. PLoS One, 9(5), e97002-1-e97002-7.
DOI Scopus27 WoS22 Europe PMC18
2014 Turner, R., & Vink, R. (2014). NK1 tachykinin receptor treatment is superior to capsaicin pre-treatment in improving functional outcome following acute ischemic stroke. Neuropeptides, 48(5), 267-272.
DOI Scopus19 WoS15 Europe PMC14
2014 Giacci, M., Wheeler, L., Lovett, S., Dishington, E., Majda, B., Bartlett, C., . . . Fitzgerald, M. (2014). Differential effects of 670 and 830 nm red near infrared irradiation therapy: a comparative study of optic nerve injury, retinal degeneration, traumatic brain and spinal cord injury. PLoS One, 9(8), e104565-1-e104565-15.
DOI Scopus46 WoS40 Europe PMC32
2014 Thornton, E., Hassall, M., Corrigan, F., & Vink, R. (2014). The NK1 receptor antagonist N-acetyl-l-tryptophan reduces dyskinesia in a hemi-parkinsonian rodent model. Parkinsonism and Related Disorders, 20(5), 508-513.
DOI Scopus24 WoS23 Europe PMC24
2014 Bates, K., Vink, R., Martins, R., & Harvey, A. (2014). Aging, cortical injury and Alzheimer's disease-like pathology in the guinea pig brain. Neurobiology of Aging, 35(6), 1345-1351.
DOI Scopus23 WoS21 Europe PMC19
2014 Harford-Wright, E., Lewis, K., Vink, R., & Ghabriel, M. N. (2014). Evaluating the role of substance P in the growth of brain tumors. Neuroscience, 261, 85-94.
DOI Scopus23 WoS20 Europe PMC17
2014 Corrigan, F., Thornton, E., Roisman, L., Leonard, A., Vink, R., Blumbergs, P., . . . Cappai, R. (2014). The neuroprotective activity of the amyloid precursor protein against traumatic brain injury is mediated via the heparin binding site in residues 96-110. Journal of Neurochemistry, 128(1), 196-204.
DOI Scopus48 WoS46 Europe PMC40
2013 Leonard, A., Thornton, E., & Vink, R. (2013). Substance P as a mediator of neurogenic inflammation after balloon compression induced spinal cord injury. Journal of Neurotrauma, 30(21), 1812-1823.
DOI Scopus24 WoS19 Europe PMC21
2013 Gabrielian, L., Helps, S., Thornton, E., Turner, R., Leonard, A., & Vink, R. (2013). Substance P antagonists as a novel intervention for brain edema and raised intracranial pressure. Acta Neurochirurgica Supplement, Brain edema XV, 118, 201-204.
DOI Scopus39 Europe PMC34
2013 Leonard, A., & Vink, R. (2013). The effect of an NK1 receptor antagonist on blood spinal cord barrier permeability following balloon compression-induced spinal cord injury. Acta Neurochirurgica Supplement, Brain edema XV, 118, 303-306.
DOI Scopus7 Europe PMC4
2013 Lewis, K., Turner, R., & Vink, R. (2013). Blocking neurogenic inflammation for the treatment of acute disorders of the central nervous system. International Journal of Inflammation, 2013(578480), 1-16.
DOI Scopus25 WoS22 Europe PMC16
2013 Fitzgerald, M., Hodgetts, S., Van Den Heuvel, C., Natoli, R., Hart, N., Valter, K., . . . Dunlop, S. (2013). Red/near-infrared irradiation therapy for treatment of central nervous system injuries and disorders. Reviews in the Neurosciences, 24(2), 205-226.
DOI Scopus74 WoS62 Europe PMC54
2013 Harford-Wright, E., Lewis, K., & Vink, R. (2013). The potential for substance P antagonists as anti-cancer agents in brain tumours. Recent Patents on CNS Drug Discovery, 8(1), 13-23.
DOI Scopus9 Europe PMC7
2013 Lewis, K., Harford-Wright, E., Vink, R., & Ghabriel, M. (2013). NK1 receptor antagonists and dexamethasone as anticancer agents in vitro and in a model of brain tumours secondary to breast cancer. Anti-Cancer Drugs, 24(4), 344-354.
DOI Scopus16 WoS14 Europe PMC13
2013 Lewis, K., Harford-Wright, E., Vink, R., & Ghabriel, M. (2013). Characterisation of Walker 256 breast carinoma cells from two tumour cell banks as assessed using two models of secondary brain tumours. Cancer Cell International, 13(5), 1-12.
DOI Scopus13 WoS14 Europe PMC14
2013 Finnie, J., Blumbergs, P., Manavis, J., & Vink, R. (2013). Pattern of cerebrospinal immediate early gene c-fos expression in an ovine model of non-accidental head injury. Journal of Clinical Neuroscience, 20(12), 1759-1761.
DOI Scopus2 WoS9 Europe PMC9
2013 Byard, R., & Vink, R. (2013). Speed of development of cerebral swelling following blunt cranial trauma. Journal of Forensic and Legal Medicine, 20(6), 598-600.
DOI Scopus8 WoS8 Europe PMC7
2013 Lewis, K., Harford-Wright, E., Vink, R., Nimmo, A., & Ghabriel, M. (2013). Walker 256 tumour cells increase substance P immunoreactivity locally and modify the properties of the blood-brain barrier during extravasation and brain invasion. Clinical & Experimental Metastasis, 30(1), 1-12.
DOI Scopus26 WoS20 Europe PMC22
2013 Turner, R., & Vink, R. (2013). The role of substance P in ischaemic brain injury. Brain Sciences, 3(1), 123-142.
DOI Scopus19 WoS17 Europe PMC14
2013 Finnie, J. W., Blumbergs, P. C., Manavis, J., & Vink, R. (2013). Pattern of cerebrospinal immediate early gene c-fos expression in an ovine model of non-accidental head injury. Journal of Clinical Neuroscience, 20(12), 1759-1761.
DOI Scopus9
2012 Helps, S., Thornton, E., Kleinig, T., Manavis, J., & Vink, R. (2012). Automatic nonsubjective estimation of antigen content visualized by immunohistochemistry using color deconvolution. Applied Immunohistochemistry and Molecular Morphology, 20(1), 82-90.
DOI Scopus62 WoS59 Europe PMC47
2012 Byard, R., Elliott, J., & Vink, R. (2012). Infant gender, shared sleeping and sudden death. Journal of Paediatrics and Child Health, 48(6), 517-519.
DOI Scopus27 WoS18 Europe PMC12
2012 Corrigan, F., Vink, R., Blumbergs, P., Masters, C., Cappai, R., & Van Den Heuvel, C. (2012). sAPPα rescues deficits in amyloid precursor protein knockout mice following focal traumatic brain injury. Journal of Neurochemistry, 122(1), 208-220.
DOI Scopus70 WoS67 Europe PMC57
2012 Corrigan, F., Leonard, A., Ghabriel, M., Van Den Heuvel, C., & Vink, R. (2012). A Substance P Antagonist Improves Outcome in Female Sprague Dawley Rats Following Diffuse Traumatic Brain Injury. CNS Neuroscience & Therapeutics, 18(6), 513-515.
DOI Scopus25 WoS22 Europe PMC19
2012 Carthew, H., Ziebell, J., & Vink, R. (2012). Substance P-induced changes in cell genesis following diffuse traumatic brain injury. Neuroscience, 214, 78-83.
DOI Scopus29 WoS26 Europe PMC22
2012 Corrigan, F., Vink, R., Blumbergs, P., Masters, C., Cappai, R., & Van Den Heuvel, C. (2012). Characterisation of the effect of knockout of the amyloid precursor protein on outcome following mild traumatic brain injury. Brain Research, 1451, 87-99.
DOI Scopus37 WoS36 Europe PMC35
2012 Barry, C., Turner, R., Corrigan, F., & Vink, R. (2012). New therapeutic approaches to subarachnoid hemorrhage. Expert Opinion on Investigational Drugs, 21(6), 845-859.
DOI Scopus21 WoS14 Europe PMC14
2012 Corrigan, F., Vink, R., Blumbergs, P., Masters, C., Cappai, R., & Van Den Heuvel, C. (2012). Evaluation of the effects of treatment with sAPPα on functional and histological outcome following controlled cortical impact injury in mice. Neuroscience Letters, 515(1), 50-54.
DOI Scopus17 WoS17 Europe PMC15
2012 Thornton, E., & Vink, R. (2012). Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's Disease. PLoS One, 7(4), 1-8.
DOI Scopus82 WoS85 Europe PMC66
2012 Turner, R., & Vink, R. (2012). Combined tissue plasminogen activator and an NK1 tachykinin receptor antagonist: an effective treatment for reperfusion injury following acute ischemic stroke in rats. Neuroscience, 220, 1-10.
DOI Scopus29 WoS27 Europe PMC23
2012 Sandoz, B., Dutschke, J., Liu, Q., Manavis, J., Finnie, J., Vink, R., & Anderson, R. (2012). In vivo biomechanical response of ovine heads to shaken baby syndrome events. Computer Methods in Biomechanics and Biomedical Engineering, 15(S1), 293-294.
DOI Scopus8 Europe PMC5
2012 Leong, W., Henshall, T., Arthur, A., Kremer, K., Lewis, M., Helps, S., . . . Koblar, S. (2012). Human adult dental pulp stem cells enhance poststroke functional recovery through non-neural replacement mechanisms. Stem Cells Translational Medicine, 1(3), 177-187.
DOI Scopus154 WoS135 Europe PMC124
2012 Elliott, J., Vink, R., Jensen, L., & Byard, R. (2012). Brain weight-body weight ratio in sudden infant death syndrome revisited. Medicine Science and the Law, 52(4), 207-209.
DOI Scopus10 WoS10 Europe PMC10
2012 Barry, C., Van Den Heuvel, C., Helps, S., & Vink, R. (2012). Cushing's mechanism maintains cerebral perfusion pressure in experimental subarachnoid haemorrhage. Neuroscience Letters, 529(1), 92-96.
DOI Scopus2 WoS2 Europe PMC2
2012 Lewis, K., Harford-Wright, E., Vink, R., & Ghabriel, M. (2012). Targeting classical but not neurogenic inflammation reduces peritumoral oedema in secondary brain tumours. Journal of Neuroimmunology, 250(1-2), 59-65.
DOI Scopus8 WoS5 Europe PMC6
2012 Wells, A., Vink, R., Blumbergs, P., Brophy, B., Helps, S., Knox, S., & Turner, R. (2012). A surgical model of permanent and transient middle cerebral artery stroke in the sheep. PLoS One, 7(7), 1-9.
DOI Scopus50 WoS50 Europe PMC42
2012 Finnie, J., Blumbergs, P., Manavis, J., Turner, R., Helps, S., Vink, R., . . . Anderson, R. (2012). Neuropathological changes in a lamb model of non-accidental head injury (the shaken baby syndrome). Journal of Clinical Neuroscience, 19(8), 1159-1164.
DOI Scopus70 WoS58 Europe PMC46
2012 Vink, R., & Byard, R. (2012). Alcohol intoxication may exacerbate the effects of blunt cranial trauma through changes in brain free magnesium levels. Journal of Forensic Sciences, 57(4), 979-982.
DOI Scopus8 WoS6 Europe PMC3
2012 Byard, R., Gabrielian, L., Helps, S., Thornton, E., & Vink, R. (2012). Further Investigations into the speed of cerebral swelling following blunt cranial trauma. Journal of Forensic Sciences, 57(4), 973-975.
DOI Scopus24 WoS22 Europe PMC17
2011 Wheaton, P., Mathias, J., & Vink, R. (2011). Impact of pharmacological treatments on outcome in adult rodents after traumatic brain injury: a meta-analysis. Journal of Psychopharmacology, 25(12), 1581-1599.
DOI Scopus24 WoS19 Europe PMC18
2011 Gabrielian, L., Willshire, L., Helps, S., Van Den Heuvel, C., Mathias, J., & Vink, R. (2011). Intracranial pressure changes following traumatic brain injury in rats: Lack of significant change in the absence of mass lesions or hypoxia. Journal of Neurotrauma, 28(10), 2103-2111.
DOI Scopus25 WoS24 Europe PMC23
2011 Wheaton, P., Mathias, J., & Vink, R. (2011). Impact of pharmacological treatments on cognitive and behavioral outcome in the postacute stages of adult traumatic brain injury: A meta-analysis. Journal of Clinical Psychopharmacology, 31(6), 745-757.
DOI Scopus70 WoS55 Europe PMC48
2011 Harford-Wright, E., Lewis, K., & Vink, R. (2011). Towards drug discovery for brain tumours: interaction of kinins and tumours at the blood brain barrier interface. Recent Patents on CNS Drug Discovery, 6(1), 31-40.
DOI Scopus19 Europe PMC6
2011 Corrigan, F., Pham, C., Vink, R., Blumbergs, P., Masters, C., Van Den Heuvel, C., & Cappai, R. (2011). The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domains. Brain Research, 1378, 137-143.
DOI Scopus66 WoS66 Europe PMC57
2011 Barry, C., Helps, S., Van Den Heuvel, C., & Vink, R. (2011). Characterizing the role of the neuropeptide substance P in experimental subarachnoid hemorrhage. Brain Research, 1389, 143-151.
DOI Scopus25 WoS23 Europe PMC22
2011 Turner, R., Helps, S., Thornton, E., & Vink, R. (2011). A substance P antagonist improves outcome when administered 4 h after onset of ischaemic stroke. Brain Research, 1393, 84-90.
DOI Scopus56 WoS49 Europe PMC48
2011 Donkin, J., Cernak, I., Blumbergs, P., & Vink, R. (2011). A substance P antagonist reduces axonal injury and improves neurologic outcome when administered up to 12 hours after traumatic brain injury. Journal of Neurotrauma, 28(2), 217-224.
DOI Scopus55 WoS52 Europe PMC48
2011 Corrigan, F., Ziebell, J., & Vink, R. (2011). Models of rodent cortical traumatic brain injury. Neuromethods, 62, 193-209.
DOI Scopus3
2010 Thornton, E., Ziebell, J., Leonard, A., & Vink, R. (2010). Kinin receptor antagonists as potential neuroprotective agents in central nervous system injury. Molecules, 15(9), 6598-6618.
DOI Scopus38 WoS39 Europe PMC36
2010 Harford-Wright, E., Thornton, E., & Vink, R. (2010). Angiotensin-converting enzyme (ACE) inhibitors exacerbate histological damage and motor deficits after experimental traumatic brain injury. Neuroscience Letters, 481(1), 26-29.
DOI Scopus41 WoS37 Europe PMC34
2010 Thornton, E., Tran, T., & Vink, R. (2010). A substance P mediated pathway contributes to 6-hydroxydopamine induced cell death. Neuroscience Letters, 481(1), 64-67.
DOI Scopus24 WoS20 Europe PMC18
2010 Zacest, A., Vink, R., Manavis, J., Sarvestani, G., & Blumbergs, P. (2010). Substance P immunoreactivity increases following human traumatic brain injury. Acta Neurochirurgica. Supplementum, 106(Supplement 106), 211-216.
DOI Scopus25 WoS34 Europe PMC31
2010 Vink, R., & Bullock, R. (2010). Traumatic brain injury: Therapeutic challenges and new directions. Neurotherapeutics, 7(1), 1-2.
DOI Scopus31 WoS36 Europe PMC32
2010 Vink, R., & Van Den Heuvel, C. (2010). Substance P antagonists as a therapeutic approach to improving outcome following traumatic brain injury. Neurotherapeutics, 7(1), 74-80.
DOI Scopus49 WoS41 Europe PMC35
2010 Donkin, J., & Vink, R. (2010). Mechanisms of cerebral edema in traumatic brain injury: Therapeutic developments. Current Opinion in Neurology, 23(3), 293-299.
DOI Scopus307 WoS279 Europe PMC250
2010 Cook, N., Vink, R., Helps, S., Manavis, J., & Van Den Heuvel, C. (2010). Transient receptor potential melastatin 2 expression is increased following experimental traumatic brain injury in rats. Journal of Molecular Neuroscience, 42(2), 192-199.
DOI Scopus37 WoS33 Europe PMC26
2010 Cook, N., Kleinig, T., Van Den Heuvel, C., & Vink, R. (2010). Reference genes for normalising gene expression data in collagenase-induced rat intracerebral haemorrhage. BMC Molecular Biology, 11(7), 1-11.
DOI Scopus19 WoS17 Europe PMC19
2010 Ghabriel, M., Zdziarski, I., Leigh, C., & Vink, R. (2010). Changes in the blood-CSF barrier in experimental traumatic brain injury. Proceedings of Brain Edema XIV, 106(Supplement 106), 239-246.
DOI Scopus9 WoS9 Europe PMC9
2010 Cernak, I., Chang, T., Ahmed, F., Cruz, M., Vink, R., Stoica, B., & Faden, A. (2010). Pathophysiological response to experimental diffuse brain trauma differs as a function of developmental age. Developmental Neuroscience, 32(5-6), 442-453.
DOI Scopus33 WoS28 Europe PMC29
2010 Thornton, E., Hassall, M., & Vink, R. (2010). Substance P antagonists reduce onset of experimental L-DOPA induced dyskinesia. Movement Disorders, 25(S2), 211-212.
DOI
2009 Wheaton, P., Mathias, J. L., & Vink, R. (2009). Impact of early pharmacological treatment on cognitive and behavioral outcome after traumatic brain injury in adults : a meta-analysis. Journal of clinical psychopharmacology, 29(5), 468-477.
DOI
2009 Cook, N., Van Den Heuvel, C., & Vink, R. (2009). Are the transient receptor potential melastatin (TRPM) channels important in magnesium homeostasis following traumatic brain injury?. Magnesium Research, 22(4), 225-234.
DOI Scopus20 WoS14 Europe PMC8
2009 Wheaton, P., Mathias, J., & Vink, R. (2009). Impact of early pharmacological treatment on cognitive and behavioral outcome after traumatic brain injury in adults A meta-analysis. Journal of Clinical Psychopharmacology, 29(5), 468-477.
DOI Scopus47 WoS36 Europe PMC37
2009 Vink, R., Cook, N., & Van Den Heuvel, C. (2009). Magnesium in acute and chronic brain injury: an update. Magnesium Research, 22(3), 158S-162S.
DOI Scopus43 WoS38 Europe PMC21
2009 Nimmo, A., & Vink, R. (2009). Recent patents in CNS drug discovery: the management of inflammation in the central nervous system.. Recent Patents on CNS Drug Discovery, 4(2), 86-95.
DOI Scopus57 Europe PMC49
2009 Kleinig, T., Helps, S., Ghabriel, M., Manavis, J., Leigh, C., Blumbergs, P., & Vink, R. (2009). Hemoglobin crystals: A pro-inflammatory potential confounder of rat experimental intracerebral hemorrhage. Brain Research, 1287, 164-172.
DOI Scopus21 WoS17 Europe PMC14
2009 Byard, R., & Vink, R. (2009). The second impact syndrome. Forensic Science, Medicine, and Pathology, 5(1), 36-38.
DOI Scopus31 WoS24 Europe PMC20
2009 Donkin, J., Nimmo, A., Cernak, I., Blumbergs, P., & Vink, R. (2009). Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury. Journal of Cerebral Blood Flow and Metabolism, 29(8), 1388-1398.
DOI Scopus134 WoS114 Europe PMC106
2009 Byard, R., Bhatia, K., Reilly, P., & Vink, R. (2009). How rapidly does cerebral swelling follow trauma? Observations using an animal model and possible implications in infancy. Legal Medicine, 11(SUPPL. 1), 128-131.
DOI Scopus24 Europe PMC17
2009 Kleinig, T., & Vink, R. (2009). Suppression of inflammation in ischemic and hemorrhagic stroke: therapeutic options. Current Opinion in Neurology, 22(3), 294-301.
DOI Scopus117 WoS112 Europe PMC97
2009 Longstreet, D., & Vink, R. (2009). Correlation between total and ionic magnesium concentration in human serum samples is independent of ethnicity or diabetic state. Magnesium Research, 22(1), 32-36.
DOI Scopus6 WoS4 Europe PMC2
2009 Cook, N., Vink, R., Donkin, J., & Van Den Heuvel, C. (2009). Validation of reference genes for normalization of real-time quantitative RT-PCR data in traumatic brain injury. Journal of Neuroscience Research, 87(1), 34-41.
DOI Scopus48 WoS49 Europe PMC44
2009 Vink, R., & Nimmo, A. (2009). Multifunctional Drugs for Head Injury. Neurotherapeutics, 6(1), 28-42.
DOI Scopus135 WoS120 Europe PMC106
2009 Newcombe, R., Blumbergs, P., Finnie, J., Reilly, P., Manavis, J., & Vink, R. (2009). Functional and Pathologic studies of experimental chronic compressive spinal cord injury and the effects of decompression. Journal of Neurotrauma, 26(8), 62.
2009 Nimmo, A., Donkin, J., Ghabriel, M., & Vink, R. (2009). NK1 tachykinin receptor antagonists prevent altered blood-brain barrier function following trauma. Neuropeptides, 43(5), 442.
2008 Longstreet, D., Heath, D., Savage, I., Vink, R., & Panaretto, K. (2008). Estimated nutrient intake of urban Indigenous participants enrolled in a lifestyle intervention program. Nutrition & Dietetics, 65(2), 128-133.
DOI Scopus10 WoS9
2008 Vink, R., Bahtia, K., & Reilly, P. (2008). The relationship between intracranial pressure and brain oxygenation following traumatic brain injury in sheep. Acta Neurochirurgica, 102(102), 189-192.
DOI Scopus22 WoS19 Europe PMC15
2008 Vink, R., Bahtia, K., & Reilly, P. (2008). The relationship between intracranial pressure and brain oxygenation following traumatic brain injury in sheep. Acta neurochirurgica supplementum, Supplement 102, 189-192.
DOI
2007 Turner, R., & Vink, R. (2007). Inhibition of neurogenic inflammation as a novel treatment for ischemic stroke. Timely Topics in Medicine. Cardiovascular Diseases, 11, E24.
DOI Scopus12 Europe PMC8
2007 O'Connor, C., Cernak, I., Johnson, F., & Vink, R. (2007). Effects of progesterone on neurologic and morphologic outcome following diffuse traumatic brain injury in rats. Experimental Neurology, 205(1), 145-153.
DOI Scopus99 WoS90 Europe PMC73
2007 Donkin, J., Turner, R., Hassan, I., & Vink, R. (2007). Substance P in traumatic brain injury. Progress in Brain Research, 161, 97-109.
DOI Scopus70 WoS58 Europe PMC54
2007 Van Den Heuvel, C., Thornton, E., & Vink, R. (2007). Traumatic brain injury and Alzheimer's disease: a review. Progress in Brain Research, 161, 303-316.
DOI Scopus192 WoS169 Europe PMC139
2007 Longstreet, D., Heath, D., Panaretto, K., & Vink, R. (2007). Correlations suggest low magnesium may lead to higher rates of type 2 diabetes in Indigenous Australians?. Rural and Remote Health, Online(7), WWW1-WWW13.
2007 Turner, R., & Vink, R. (2007). Inhibition of neurogenic inflammation as a novel treatment for ischemic stroke. Drug News & Perspectives, 20(4), 221-226.
DOI Scopus18 WoS19 Europe PMC17
2007 Longstreet, D. A., Heath, D. L., Panaretto, K. S., & Vink, R. (2007). Correlations suggest low magnesium may lead to higher rates of type 2 diabetes in Indigenous Australians.. Rural and Remote Health, 7(4), 843.
DOI Scopus17 Europe PMC8
2006 Thornton, E., Vink, R., Blumbergs, P., & Van Den Heuvel, C. (2006). Soluble amyloid precursor protein a reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats. Brain Research, 1094(1), 38-46.
DOI Scopus156 WoS147 Europe PMC132
2006 Wheaton, P., Mathias, J. L., & Vink, R. (2006). Impact of pharmacological treatments on cognitive and behavioural outcome following traumatic brain injury in adults: A meta-analysis. AUSTRALIAN JOURNAL OF PSYCHOLOGY, 58, 232.
2005 Longstreet, D., Heath, D., & Vink, R. (2005). A potential link between magnesium intake and diabetes in Indigenous Australians. Medical Journal of Australia, 183(4), 219-220.
DOI Scopus4 WoS6 Europe PMC3
2005 O'Connor, C., Cernak, I., & Vink, R. (2005). Both estrogen and progesterone attenuate edema formation following diffuse traumatic brain injury in rats. Brain Research, 1062(1-2), 171-174.
DOI Scopus147 WoS134 Europe PMC116
2005 Howard, C., Donkin, J., Ghabriel, M., Blumbergs, P., & Vink, R. (2005). A substance P antagonist increases aquaporin-4 expression and reduces oedema after traumatic brain injury. Restorative Neurology and Neuroscience, 23 (3-4), 194.
2004 Vink, R. (2004). Meeting report: 10th international magnesium symposium. Magnesium Research, 17(2), 151-153.
2004 Turner, R., Van Den Heuvel, C., & Vink, R. (2004). Amiloride increases neuronal damage after traumatic brain injury in rats. Journal of the American College of Nutrition, 23(5), 534S-537S.
DOI Scopus10 WoS11 Europe PMC7
2004 Movesesyan, V., Stoica, B., Yakovlev, A., Knoblach, S., Lea, P., Cernak, I., . . . Faden, A. (2004). Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathways. Cell Death and Differentiation, 11(10), 1121-1132.
DOI Scopus79 WoS68 Europe PMC57
2004 Vink, R., Donkin, J., Cruz, M., Nimmo, A., & Cernak, I. (2004). A substance P antagonist increases brain intracellular free magnesium concentration after diffuse traumatic brain injury in rats. Journal of the American College of Nutrition, 23(5), 538S-540S.
DOI Scopus33 WoS29 Europe PMC26
2004 Fromm, L., Heath, D., Vink, R., & Nimmo, A. (2004). Magnesium attenuates post-traumatic depression/anxiety following diffuse traumatic brain injury in rats. Journal of the American College of Nutrition, 23(5), 529S-233S.
DOI Scopus79 WoS63 Europe PMC53
2004 Turner, R., Da Silva, K., O'Connor, C., Van Den Heuvel, C., & Vink, R. (2004). Magnesium gluconate offers no more protection than magnesium sulphate following diffuse traumatic brain injury in rats. Journal of the American College of Nutrition, 23(5), 541S-544S.
DOI Scopus17 WoS11 Europe PMC6
2004 Van Den Heuvel, C., Donkin, J., Finnie, J., Blumbergs, P., Kuchel, T., Koszyca, B., . . . Vink, R. (2004). Downregulation of amyloid precursor protein (APP) expression following post-traumatic cyclosporin-A administration. Journal of Neurotrauma, 21(11), 1562-1572.
DOI Scopus29 WoS27 Europe PMC23
2004 Vink, R., & Van Den Heuvel, C. (2004). Recent advances in the development of multifactorial therapies for the treatment of traumatic brain injury. Expert Opinion on Investigational Drugs, 13(10), 1263-1274.
DOI Scopus55 WoS50 Europe PMC41
2004 Cernak, I., Vink, R., Zapple, D., Cruz, M., Ahmed, F., Chang, T., . . . Faden, A. (2004). The pathobiology of moderate diffuse traumatic brain injury as identified using a new experimental model of injury in rats. Neurobiology of Disease, 17(1), 29-43.
DOI Scopus146 WoS129 Europe PMC115
2004 Fricke, S., Vink, R., Chiodo, C., Cernak, I., Ileva, L., & Faden, A. (2004). Consistent and reproducible slice selection in rodent brain using a novel stereotaxic device for MRI. Journal of Neuroscience Methods, 136(1), 99-102.
DOI Scopus25 WoS24 Europe PMC21
2004 Cernak, I., Vink, R., Natale, J., Stoica, B., Lea, P., Movesesyan, V., . . . Faden, A. (2004). The "dark side" of endocannabinoids: A neurotoxic role for anandamide. Journal of Cerebral Blood Flow and Metabolism, 24(5), 564-578.
DOI Scopus54 WoS53 Europe PMC41
2004 Nimmo, A., Cernak, I., Heath, D., Hu, X., Bennett, C., & Vink, R. (2004). Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats. Neuropeptides, 38(1), 40-47.
DOI Scopus129 WoS120 Europe PMC97
2004 Van Den Heuvel, C., & Vink, R. (2004). The role of magnesium in traumatic brain injury. Clinical Calcium, 14(8), 9-14.
Scopus39 Europe PMC20
2003 Faden, A., Knoblach, S., Cernak, I., Fan, L., Vink, R., Araldi, G., . . . Kozikowski, A. (2003). Novel diketopiperazine enhances motor and cognitive recovery after traumatic brain injury in rats and shows neuroprotection In Vitro and In Vivo. Journal of Cerebral Blood Flow and Metabolism, 23(3), 342-354.
DOI Scopus71 WoS67 Europe PMC56
2003 Vink, R., Young, A., Bennett, C., Hu, X., O'Connor, C., Cernak, I., & Nimmo, A. (2003). Neuropeptide release influences brain edema formation after diffuse traumatic brain injury. Acta Neurochirurgica. Supplementum, 86(86), 257-260.
DOI Scopus67 WoS60 Europe PMC42
2003 O'Connor, C., Heath, D., Cernak, I., Nimmo, A., & Vink, R. (2003). Effects of daily versus weekly testing and pre-training on the assessment of neurologic impairment following diffuse traumatic brain injury in rats. Journal of Neurotrauma, 20(10), 985-993.
DOI Scopus34 WoS31 Europe PMC29
2003 Pamphlett, R., Todd, E., Vink, R., McQuilty, R., & Cheema, S. (2003). Magnesium supplementation does not delay disease onset or increase survival in a mouse model of familial ALS. Journal of the Neurological Sciences, 216(1), 95-98.
DOI Scopus12 WoS13 Europe PMC10
2003 Vink, R., O'Connor, C., Nimmo, A., & Heath, D. (2003). Magnesium attenuates persistent functional deficits following diffuse traumatic brain injury in rats. Neuroscience Letters, 336(1), 41-44.
DOI Scopus90 WoS70 Europe PMC55
2003 O'Connor, C., Cernak, I., & Vink, R. (2003). Interaction between anesthesia, gender, and functional outcome task following diffuse traumatic brain injury in rats. Journal of Neurotrauma, 20(6), 533-541.
DOI Scopus81 WoS74 Europe PMC70
2002 Vink, R., & Nimmo, A. (2002). Novel therapies in development for the treatment of traumatic brain injury. Expert Opinion on Investigational Drugs, 11(10), 1375-1386.
DOI Scopus38 WoS32 Europe PMC25
2002 Cernak, I., OConnor, C., & Vink, R. (2002). Inhibition of cyclooxygenase 2 by nimesulide improves cognitive outcome more than motor outcome following diffuse traumatic brain injury in rats. Experimental Brain Research, 147(2), 193-199.
DOI Scopus89 WoS82 Europe PMC67
2002 Cernak, I., Chapman, S., Hamlin, G., & Vink, R. (2002). Temporal characterisation of pro- and anti-apoptotic mechanisms following diffuse traumatic brain injury in rats. Journal of Clinical Neuroscience, 9(5), 565-572.
DOI Scopus42 WoS38 Europe PMC33
2002 Nimmo, A., Carstairs, J., Patole, S., Whitehall, J., Davidson, K., & Vink, R. (2002). Intratracheal administration of glucocorticoids using surfactant as a vehicle. Clinical and Experimental Pharmacology and Physiology, 29(8), 661-665.
DOI Scopus56 WoS51 Europe PMC38
2001 Vink, R., Nimmo, A., & Cernak, I. (2001). An overview of new and novel pharmacotherapies for use in traumatic brain injury. Clinical and Experimental Pharmacology and Physiology, 28(11), 919-921.
DOI Scopus45 WoS42 Europe PMC35
2001 Cernak, I., O'Connor, C., & Vink, R. (2001). Activation of cyclo-oxygenase-2 contributes to motor and cognitive dysfunction following diffuse traumatic brain injury in rats. Clinical and Experimental Pharmacology and Physiology, 28(11), 922-925.
DOI Scopus60 WoS57 Europe PMC50
2001 Heath, D., & Vink, R. (2001). Subdural hematoma following traumatic brain injury causes a secondary decline in brain free magnesium concentration. Journal of Neurotrauma, 18(4), 465-469.
DOI Scopus18 WoS17 Europe PMC14
2001 Russell, M., & Vink, R. (2001). Increased facial temperature as an early warning in Sudden Infant Death Syndrome. Medical Hypotheses, 57(1), 61-63.
DOI Scopus13 WoS11 Europe PMC10
2001 Vink, R., Mullins, P., Temple, M., Bao, W., & Faden, A. (2001). Small shifts in craniotomy position in the lateral fluid percussion injury model are associated with differential lesion development. Journal of Neurotrauma, 18(8), 839-847.
DOI Scopus75 WoS66 Europe PMC58
2001 Hamlin, G., Cernak, I., Wixey, J., & Vink, R. (2001). Increased expression of neuronal glucose transporter 3 but not glial glucose transporter 1 following severe diffuse traumatic brain injury in rats. Journal of Neurotrauma, 18(10), 1011-1018.
DOI Scopus65 WoS63 Europe PMC53
2000 Alexiou, T., Crane, L. H., & Vink, R. (2000). Increased mortality in female rats after severe diffuse traumatic brain injury is significantly attenuated by magnesium administration. Neuroscience Research Communications, 26(1), 1-8.
DOI Scopus3 WoS11
2000 Vink, R., & Cernak, I. (2000). Regulation of intracellular free magnesium in central nervous system injury.. Frontiers in Bioscience A Journal and Virtual Library, 5(1), D656-D665.
DOI Scopus76 WoS64 Europe PMC37
1999 Heath, D. L., & Vink, R. (1999). Optimization of magnesium therapy after severe diffuse axonal brain injury in rats. Journal of Pharmacology and Experimental Therapeutics, 288(3), 1311-1316.
DOI Scopus86 WoS75 Europe PMC40
1999 Almonte, R. A., Heath, D. L., Whitehall, J., Russell, M. J., Patole, S., & Vink, R. (1999). Gestational magnesium deficiency is deleterious to fetal outcome. Biology of the Neonate, 76(1), 26-32.
DOI Scopus44 WoS30 Europe PMC25
1999 Heath, D. L., & Vink, R. (1999). Improved motor outcome in response to magnesium therapy received up to 24 hours after traumatic diffuse axonal brain injury in rats. Journal of Neurosurgery, 90(3), 504-509.
DOI Scopus87 WoS80 Europe PMC55
1999 Heath, D. L., & Vink, R. (1999). Brain free magnesium concentration is predictive of motor outcome following traumatic axonal brain injury in rats. Magnesium Research, 12(4), 269-277.
Scopus23 WoS24 Europe PMC14
1999 Heath, D. L., & Vink, R. (1999). Concentration of brain free magnesium following severe brain injury correlates with neurologic motor outcome. Journal of Clinical Neuroscience, 6(6), 505-509.
DOI Scopus17 WoS15 Europe PMC8
1999 de Sousa, R. M. C. (1999). Traumatic brain injury. REVISTA DE SAUDE PUBLICA, 33(5), 531-532.
1999 Heath, D. L., & Vink, R. (1999). Secondary mechanisms in traumatic brain injury: a nurse's perspective.. Journal of Neuroscience Nursing Journal of the American Association of Neuroscience Nurses, 31(2), 97-105.
DOI Scopus7 Europe PMC5
1998 Heath, D. L., & Vink, R. (1998). Blood-free magnesium concentration declines following graded experimental traumatic brain injury. Scandinavian Journal of Clinical and Laboratory Investigation, 58(2), 161-166.
DOI Scopus29 WoS27 Europe PMC14
1998 Heath, D. L., & Vink, R. (1998). Neuroprotective effects of MgSO4 and MgCl2 in closed head injury: A comparative phosphorus NMR study. Journal of Neurotrauma, 15(3), 183-189.
DOI Scopus65 WoS61 Europe PMC41
1997 Vink, R., Golding, E. M., Williams, J. P., & McIntosh, T. K. (1997). Blood glucose concentration does not affect outcome in brain trauma: A 31P MRS study. Journal of Cerebral Blood Flow and Metabolism, 17(1), 50-53.
DOI Scopus27 WoS24 Europe PMC21
1997 Heath, D. L., & Vink, R. (1997). Magnesium sulphate improves neurologic outcome following severe closed head injury in rats. Neuroscience Letters, 228(3), 175-178.
DOI Scopus39 WoS34 Europe PMC27
1996 Vink, R., Heath, D. L., & McIntosh, T. K. (1996). Acute and prolonged alterations in brain free magnesium following fluid percussion-induced brain trauma in rats. Journal of Neurochemistry, 66(6), 2477-2483.
DOI Scopus66 WoS66 Europe PMC39
1996 Budden, L., & Vink, R. (1996). Paracetamol overdose: pathophysiology and nursing management.. British Journal of Nursing Mark Allen Publishing, 5(3), 145-152.
DOI Scopus2
1996 Heath, D. L., & Vink, R. (1996). Brain entracellular free magnesium declines after impact-acceleration induced brain injury in rats. Neuroscience Research Communications, 18(3), 163-168.
DOI Scopus5 WoS5
1996 Heath, D. L., & Vink, R. (1996). Traumatic brain axonal injury produces sustained decline in intracellular free magnesium concentration. Brain Research, 738(1), 150-153.
DOI Scopus69 WoS61 Europe PMC42
1995 Golding, E. M., & Vink, R. (1995). Efficacy of competitive vs noncompetitive blockade of the NMDA channel following traumatic brain injury. Molecular and Chemical Neuropathology, 24(2-3), 137-150.
DOI Scopus20 WoS25 Europe PMC14
1995 Mullins, P. G., & Vink, R. (1995). Chronic alcohol exposure decreases brain intracellular free magnesium concentration in rats. Neuroreport, 6(12), 1633-1636.
DOI Scopus21 WoS21 Europe PMC9
1995 Yamakami, I., Vink, R., Faden, A. I., Gennarelli, T. A., Lenkinski, R., & McIntosh, T. K. (1995). Effects of acute ethanol intoxication on experimental brain injury in the rat: Neurobehavioral and phosphorus-31 nuclear magnetic resonance spectroscopy studies. Journal of Neurosurgery, 82(5), 813-821.
DOI Scopus33 WoS33 Europe PMC23
1995 Headrick, J. P., Faden, A. I., & Vink, R. (1995). Intrathecal dynorphin-A infusion in rat spinal cord causes energy depletion, edema and neurologic dysfunction. Neurochemistry International, 26(5), 489-495.
DOI Scopus9 WoS8 Europe PMC9
1995 Heath, D. L., & Vink, R. (1995). Impact Acceleration-Induced Severe Diffuse Axonal Injury in Rats: Characterization of Phosphate Metabolism and Neurologic Outcome. Journal of Neurotrauma, 12(6), 1027-1034.
DOI Scopus71 WoS60 Europe PMC50
1994 Headrick, J. P., Bendall, M. R., Faden, A. I., & Vink, R. (1994). Dissociation of adenosine levels from bioenergetic state in experimental brain trauma: Potential role in secondary injury. Journal of Cerebral Blood Flow and Metabolism, 14(5), 853-861.
DOI Scopus61 WoS61 Europe PMC52
1994 Hanstock, C. C., Faden, A. I., Bendall, M. R., & Vink, R. (1994). Diffusion-weighted imaging differentiates ischemic tissue from traumatized tissue. Stroke, 25(4), 843-848.
DOI Scopus100 WoS91 Europe PMC80
1994 Vink, R., Golding, E. M., & Headrick, J. P. (1994). Bioenergetic Analysis of Oxidative Metabolism Following Traumatic Brain Injury in Rats. Journal of Neurotrauma, 11(3), 265-274.
DOI Scopus58 WoS59 Europe PMC42
1994 Golding, E. M., & Vink, R. (1994). Inhibition of phospholipase C with neomycin improves metabolic and neurologic outcome following traumatic brain injury. Brain Research, 668(1-2), 46-53.
DOI Scopus14 WoS12 Europe PMC10
1993 Vink, R. (1993). Nuclear magnetic resonance characterization of secondary mechanisms following traumatic brain injury. Molecular and Chemical Neuropathology, 18(3), 279-297.
DOI Scopus28 WoS29 Europe PMC20
1993 Emerson, C. S., Headrick, J. P., & Vink, R. (1993). Estrogen improves biochemical and neurologic outcome following traumatic brain injury in male rats, but not in females. Brain Research, 608(1), 95-100.
DOI Scopus138 WoS131 Europe PMC118
1992 Emerson, C. S., & Vink, R. (1992). Increased mortality in female rats after brain trauma is associated with lower free Mg2+. Neuroreport, 3(11), 957-960.
DOI Scopus18 WoS15 Europe PMC8
1991 Vink, R., Portoghese, P. S., & Faden, A. I. (1991). κ-Opioid antagonist improves cellular bioenergetics and recovery after traumatic brain injury. American Journal of Physiology Regulatory Integrative and Comparative Physiology, 261(6 30-6), R1527-R1532.
DOI Scopus46 Europe PMC28
1991 Vink, R. (1991). Magnesium and brain trauma.. Magnesium and Trace Elements, 10(1), 1-10.
Scopus17 Europe PMC6
1991 VINK, R., PORTOGHESE, P. S., & FADEN, A. I. (1991). KAPPA-OPIOID ANTAGONIST IMPROVES CELLULAR BIOENERGETICS AND RECOVERY AFTER TRAUMATIC BRAIN INJURY. AMERICAN JOURNAL OF PHYSIOLOGY, 261(6), R1527-R1532.
DOI WoS44
1990 Vink, R., Head, V. A., Faden, A. I., Rogers, P. J., & Mcintosh, T. K. (1990). Mitochondrial Metabolism Following Traumatic Brain Injury in Rats. Journal of Neurotrauma, 7(1), 21-27.
DOI Scopus72 WoS71 Europe PMC63
1990 Vink, R., & McIntosh, T. K. (1990). Pharmacological and physiological effects of magnesium on experimental traumatic brain injury.. Magnesium Research Official Organ of the International Society for the Development of Research on Magnesium, 3(3), 163-169.
Scopus47 Europe PMC22
1990 Faden, A. I., Yum, S. W., Lemke, M., & Vink, R. (1990). Effects of TRH-analog treatment on tissue cations, phospholipids and energy metabolism after spinal cord injury. Journal of Pharmacology and Experimental Therapeutics, 255(2), 608-614.
DOI Scopus33 WoS31 Europe PMC20
1990 Vink, R., McIntosh, T. K., Rhomhanyi, R., & Faden, A. I. (1990). Opiate antagonist nalmefene improves intracellular free Mg2+, bioenergetic state, and neurologic outcome following traumatic brain injury in rats. Journal of Neuroscience, 10(11), 3524-3530.
DOI Scopus61 WoS64 Europe PMC43
1990 McIntosh, T. K., Vink, R., Soares, H., Hayes, R., & Simon, R. (1990). Effect of Noncompetitive Blockade of N‐Methyl‐d‐Aspartate Receptors on the Neurochemical Sequelae of Experimental Brain Injury. Journal of Neurochemistry, 55(4), 1170-1179.
DOI Scopus154 WoS161 Europe PMC120
1989 McIntosh, T. K., Vink, R., Yamakami, I., & Faden, A. I. (1989). Magnesium protects against neurological deficit after brain injury. Brain Research, 482(2), 252-260.
DOI Scopus228 WoS206 Europe PMC159
1989 Mcintosh, T. K., Vink, R., Soares, H., Hayes, R., & Simon, R. (1989). Effects of the N-Methyl-D-Aspartate Receptor Blocker MK-801 on Neurologic Function After Experimental Brain Injury. Journal of Neurotrauma, 6(4), 247-259.
DOI Scopus171 WoS167 Europe PMC142
1989 McIntosh, T. K., Vink, R., Noble, L., Yamakami, I., Fernyak, S., Soares, H., & Faden, A. L. (1989). Traumatic brain injury in the rat: Characterization of a lateral fluid-percussion model. Neuroscience, 28(1), 233-244.
DOI Scopus1014 WoS988 Europe PMC869
1989 Faden, A. I., Demediuk, P., Panter, S. S., & Vink, R. (1989). The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science, 244(4906), 798-800.
DOI Scopus1381 WoS1323 Europe PMC1073
1989 Demediuk, P., Faden, A. I., Romhanyi, R., Vink, R., & McIntosh, T. K. (1989). Changes in lipid metabolism, tissue cations, and water content after fluid-percussion-induced traumatic brain injury in rats.. Journal of Neurotrauma, 6(4), 229.
DOI
1989 Demediuk, P., Faden, A. I., Romhanyi, R., Vink, R., & McIntosh, T. K. (1989). Letter to the editor. Journal of Neurotrauma, 6(4), 229.
DOI
1989 Vink, R., Noble, L. J., Knoblach, S. M., Bendall, M. R., & Faden, A. I. (1989). Metabolic changes in rabbit spinal cord after trauma: Magnetic resonance spectroscopy studies. Annals of Neurology, 25(1), 26-31.
DOI Scopus32 WoS34 Europe PMC24
1989 DEMEDIUK, P., FADEN, A. I., VINK, R., ROMHANYI, R., & MCINTOSH, T. K. (1989). EFFECTS OF TRAUMATIC BRAIN INJURY ON ARACHIDONIC-ACID METABOLISM AND BRAIN WATER-CONTENT IN THE RAT. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 559, 431-432.
WoS4
1989 FADEN, A. I., VINK, R., & McINTOSH, T. K. (1989). Thyrotropin‐Releasing Hormone and Central Nervous System Trauma. Annals of the New York Academy of Sciences, 553(1), 380-384.
DOI Scopus32 WoS13 Europe PMC11
1989 Vink, R., Yum, S. W., Lemke, M., Demediuk, P., & Faden, A. I. (1989). Traumatic spinal cord injury in rabbits decreases intracellular free magnesium concentration as measured by 31P MRS. Brain Research, 490(1), 144-147.
DOI Scopus23 WoS28 Europe PMC21
1989 Vink, R. (1989). Phospholipase C activity reduces free magnesium concentration. Biochemical and Biophysical Research Communications, 165(2), 913-918.
DOI Scopus9 WoS12 Europe PMC5
1988 Vink, R., McIntosh, T. K., & Faden, A. I. (1988). Treatment with the thyrotropin-releasing hormone analog CG3703 restores magnesium homeostasis following traumatic brain injury in rats. Brain Research, 460(1), 184-188.
DOI Scopus36 WoS43 Europe PMC20
1988 Vink, R., Faden, A. I., & Mcintosh, T. K. (1988). Changes in Cellular Bioenergetic State Following Graded Traumatic Brain Injury in Rats: Determination by Phosphorus 31 Magnetic Resonance Spectroscopy. Journal of Neurotrauma, 5(4), 315-330.
DOI Scopus78 WoS78 Europe PMC69
1988 Mcintosh, T. K., Faden, A. I., Yamakami, I., & Vink, R. (1988). Magnesium Deficiency Exacerbates and Pretreatment Improves Outcome Following Traumatic Brain Injury in Rats: 31P Magnetic Resonance Spectroscopy and Behavioral Studies. Journal of Neurotrauma, 5(1), 17-31.
DOI Scopus146 WoS140 Europe PMC98
1988 Demediuk, P., Faden, A. I., Romhanyi, R., Vink, R., & Mcintosh, T. K. (1988). Traumatic Brain Injury in the Rat: Effects on Lipid Metabolism, Tissue Magnesium, and Water Content. Journal of Neurotrauma, 5(2), 105-119.
DOI Scopus17 Europe PMC15
1988 McIntosh, T. K., Vink, R., & Faden, A. I. (1988). Beneficial effect of the TRH analog CG-3703 on outcome and survival following traumatic brain injury in rats.. Progress in Clinical and Biological Research, 264, 415-420.
Scopus4 Europe PMC1
1988 Vink, R., McIntosh, T. K., Yamakami, I., & Faden, A. I. (1988). 31P NMR characterization of graded traumatic brain injury in rats. Magnetic Resonance in Medicine, 6(1), 37-48.
DOI Scopus41 WoS46 Europe PMC39
1988 McIntosh, T. K., Vink, R., & Faden, A. I. (1988). An analogue of thyrotropin-releasing hormone improves outcome after brain injury: 31P-NMR studies. American Journal of Physiology Regulatory Integrative and Comparative Physiology, 254(5), 23/5.
DOI Scopus26 WoS32 Europe PMC13
1988 Vink, R., McIntosh, T. K., & Faden, A. I. (1988). Nonedited 1H NMR lactate/n‐acetyl aspartate ratios and the in vivo determination of lactate concentration in brain. Magnetic Resonance in Medicine, 7(1), 95-99.
DOI Scopus17 WoS21 Europe PMC14
1988 Vink, R., McIntosh, T. K., Demediuk, P., Weiner, M. W., & Faden, A. I. (1988). Decline in intracellular free Mg2+ is associated with irreversible tissue injury after brain trauma. Journal of Biological Chemistry, 263(2), 757-761.
DOI Scopus240 WoS236 Europe PMC164
1987 Vink, R., McIntosh, T. K., Demediuk, P., & Faden, A. I. (1987). Decrease in total and free magnesium concentration following traumatic brain injury in rats. Biochemical and Biophysical Research Communications, 149(2), 594-599.
DOI Scopus77 WoS81 Europe PMC52
1987 Mclntosh, T. K., Faden, A. I., Bendall, M. R., & Vink, R. (1987). Traumatic Brain Injury in the Rat: Alterations in Brain Lactate and pH as Characterized by 1H and 31P Nuclear Magnetic Resonance. Journal of Neurochemistry, 49(5), 1530-1540.
DOI Scopus107 WoS103 Europe PMC90
1987 Vink, R., Knoblach, S. M., & Faden, A. I. (1987). 31P magnetic resonance spectroscopy of traumatic spinal cord injury. Magnetic Resonance in Medicine, 5(4), 390-394.
DOI Scopus24 WoS22 Europe PMC15
1987 VINK, R., McINTOSH, T. K., FERNYAK, S. E., WEINER, M. W., & FADEN, A. I. (1987). Proton and Phosphorus NMR Studies of Traumatic Brain Injury in Rats. Annals of the New York Academy of Sciences, 508(1), 497-500.
DOI Scopus2 WoS4
1987 Lemke, M., Demediuk, P., McIntosh, T. K., Vink, R., & Faden, A. I. (1987). Alterations in tissue Mg++, Na+ and spinal cord edema following impact trauma in rats. Biochemical and Biophysical Research Communications, 147(3), 1170-1175.
DOI Scopus64 WoS63 Europe PMC54
1987 Vink, R., McIntosh, T. K., Weiner, M. W., & Faden, A. I. (1987). Effects of traumatic brain injury on cerebral high-energy phosphates and pH: a 31P magnetic resonance spectroscopy study.. Journal of Cerebral Blood Flow and Metabolism Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 7(5), 563-571.
DOI Scopus95 WoS106 Europe PMC83
1985 Singh, S. P., Bishop, C. J., Vink, R., & Rogers, P. J. (1985). Regulation of the glucose phosphotransferase system in Brochothrix thermosphacta by membrane energization. Journal of Bacteriology, 164(1), 367-378.
DOI Scopus7 WoS11 Europe PMC6
1984 Singh, S. P., Vink, R., & Rogers, P. J. (1984). Regulation of lactate dehydrogenase in Brochothrix thermosphacta. FEMS Microbiology Letters, 22(1), 73-76.
DOI Scopus3 WoS5
1984 Vink, R., Bendall, M. R., Simpson, S. J., & Rogers, P. J. (1984). Estimation of H+ to Adenosine 5′-Triphosphate Stoichiometry of Escherichia coli ATP Synthase Using 31P NMR. Biochemistry, 23(16), 3667-3675.
DOI Scopus20 WoS25 Europe PMC18
1983 SIMPSON, S. J., BENDALL, M. R., EGAN, A. F., VINK, R., & ROGERS, P. J. (1983). High‐field phosphorus NMR studies of the stoichiometry of the lactate/proton carrier in Streptococcus faecalis. European Journal of Biochemistry, 136(1), 63-69.
DOI Scopus23 WoS26 Europe PMC14
1983 Simpson, S. J., Vink, R., Egan, A. F., & Rogers, P. J. (1983). Lactate efflux stimulates [32Pi]ATP exchange in Streptococcus faecalis membrane vesicles. FEMS Microbiology Letters, 19(1), 111-114.
DOI Scopus13 WoS18

Year Citation
2024 Vink, R. (2024). Substance P in pain. In R. Vink (Ed.), Source details - Title: Substance P: from Pain to Cancer (pp. 357-372). UK: Academic Press.
DOI
2024 Hilliard, B. A., Vink, R., & Barbe, M. F. (2024). The synthesis, release, and binding of substance P. In R. Vink (Ed.), Source details - Title: Substance P: from pain to cancer (pp. 1-14). UK: Academic Press.
DOI
2024 Vink, R. (2024). Substance P: Perspectives and future directions. In R. Vink (Ed.), Source details - Title: Substance P: from Pain to Cancer (pp. 687-698). UK: Academic Press.
DOI
2024 Bright, F., Fink, R., & Byard, R. W. (2024). Substance P and sudden infant death syndrome (SIDS). In R. Vink (Ed.), Source details - Title: Substance P: from Pain to Cancer (pp. 611-623). UK: Academic Press.
DOI
2024 Vink, R. (2024). Preface - Substance P: from Pain to Cancer. In R. Vink (Ed.), Source details - Title: Substance P: from Pain to Cancer (pp. xxv-xxvi). UK: Academic Press.
DOI
2019 Vink, R. (2019). A translational model of traumatic brain injury: sheep impact acceleration. In M. Risling, & J. Davidsson (Eds.), Source details - Title: Animal models of neurotrauma (Vol. 149, pp. 243-250). US: Humana Press.
DOI Scopus1
2018 Bright, F., Vink, R., & Byard, R. (2018). Brainstem Neuropathology in Sudden Infant Death Syndrome. In J. Duncan, & R. Byard (Eds.), SIDS Sudden infant and early childhood death: The past, the present and the future (pp. 589-614). Adelaide, South Australia: University of Adelaide Press.
DOI
2015 Busingye, D., Turner, R., & Vink, R. (2015). Emerging therapies in traumatic brain injury. In D. Cifu, & B. Eapen (Eds.), Traumatic Brain Injury Rehabilitation Medicine (pp. 260-271). London: Future Medicine.
DOI
2013 Turner, R., & Vink, R. (2013). Magnesium and traumatic brain injury. In R. Wilson, V. Preedy, & S. Zibadi (Eds.), Magnesium in Human Health and Disease (1 ed., pp. 255-267). United States: Springer.
DOI
2012 Turner, R., Corrigan, F., & Vink, R. (2012). Magnesium in acute brain injury. In Y. Li, & J. Zhang (Eds.), Metal Ion in Stroke (1 ed., pp. 445-460). United States: Springer.
DOI Scopus1
2012 Ziebell, J. M., Corrigan, F., & Vink, R. (2012). Animal models of mild and severe TBI: what have we learned in the past 30 years?. In C. Morganti-Kossman, R. Raghupathi, & A. Maas (Eds.), Source details - Title: Traumatic brain and spinal cord injury: challenges and developments (pp. 114-125). UK: Cambridge University Press.
2011 Cuciureanu, M., & Vink, R. (2011). Magnesium and stress. In R. Vink, & M. Nechifor (Eds.), Magnesium in the Central Nervous System (1 ed., pp. 269-282). Australia: University of Adelaide Press.
DOI Scopus22
2011 Ghabriel, M., & Vink, R. (2011). Magnesium transport across the blood-brain barriers. In R. Vink, & M. Nechifor (Eds.), Magnesium in the Central Nervous System (1 ed., pp. 59-74). Adelaide, South Australia: University of Adelaide Press.
DOI Scopus15
2011 Vink, R., & Nechifor, M. (2011). Preface. In R. Vink (Ed.), Magnesium in the Central Nervous System (pp. viii). University of Adelaide Press.
DOI Scopus2
2011 Cuciureanu, M. D., & Vink, R. (2011). Magnesium and stress. In R. Vink, & M. Nechifor (Eds.), Source details - Title: Magnesium in the central nervous system (pp. 251-268). South Australia: University of Adelaide Press.
2009 Vink, R. (2009). Brain Injury: Magnetic Resonance Studies of Metabolic Aspects. In Encyclopedia of Neuroscience Volumes 1 11 (Vol. 2, pp. V2-V2-387).
DOI
2009 Vink, R. (2009). Brain Injury: Magnetic Resonance Studies of Metabolic Aspects. In L. R. Squire (Ed.), Encyclopedia of Neuroscience (pp. 381-387). Elsevier.
DOI
2008 Blumbergs, P., Reilly, P., & Vink, R. (2008). Trauma. In D. Graham, & P. Lantos (Eds.), Greenfield's Neuropathology (8 ed., pp. 733-812). United Kingdom: Edward Arnold Pty Ltd.
2006 Turner, R., & Vink, R. (2006). Magnesium in the central nervous system. In Y. Nishizawa, H. Morii, & J. Durlach (Eds.), New perspectives in magnesium research: Nutrition and health (pp. 338-355). UK: Springer.
DOI Scopus11 WoS11
2006 Vink, R. (2006). Magnesium: out of sight, out of mind?. In P. Porr, M. Nechifor, & J. Durlach (Eds.), Jovens, Marcas E Estilos de Vida (pp. 19-23). France: John Libbey & Company Ltd.
2005 Vink, R. (2005). Magnetic resonance spectroscopy. In P. Reilly, & R. Bullock (Eds.), Head injury: pathophysiology and management (2 ed., pp. 258-267). London: Hodder Education.
2004 Vink, R., & Cernak, I. (2004). Brain injury investigating metabolic aspects using magnetic resonance. In Encyclopedia of Neuroscience (3 ed., pp. CD ROM). Amsterdam: Elsevier.
DOI
2001 Vink, R. (2001). Magnesium in traumatic brain injury: Past findings and future directions. In Y. Rayssiguier, A. Mazur, & J. Durlach (Eds.), Advances in Magnesium Research: Nutrition and Health (pp. 405-412). PO Box 276, Eastleigh, SO50 5YS, England: John Libbey & Company Ltd.

Year Citation
2016 Turner, R., Leonard, A. V., & Vink, R. (2016). LOWERING ICP FOLLOWING STROKE: NK1 ANTAGONIST AS EFFECTIVE AS DECOMPRESSIVE SURGERY. In JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM Vol. 36 (pp. 419). Vancouver, CANADA: SAGE PUBLICATIONS INC.
2016 Dutschke, J. K., Anderson, R. W., Sandoz, B., Finnie, J., Manavis, J., Nishimoto, T., . . . Vink, R. (2016). A Biomechanical Model of Traumatic Contusional Injury Produced by Controlled Cerebrocortical Indentation in Sheep. In 2016 IRCOBI Conference Proceedings (pp. 354-368). Online: IRCOBI.
Scopus7
2015 Leonard, A., Menendez, J., Pat, B., Hadley, M., Vink, R., & Floyd, C. (2015). LOCALIZATION OF THE CORTICOSPINAL TRACT IN PIGS: IMPLICATIONS FOR MODELLING TRAUMATIC SPINAL CORD INJURY. In JOURNAL OF NEUROTRAUMA Vol. 32 (pp. A103). Santa Fe, NM: MARY ANN LIEBERT, INC.
2015 Katharesan, V., Lewis, M., Vink, R., & Johnson, I. (2015). Age-related differences in the inflammatory cytokine environment surrounding facial motoneurones. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. In Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Vol. 16 (pp. 204). Orlando, FL: Informa Healthcare.
2015 Plummer, S., Thornton, E., Corrigan, F., Vink, R., Cappai, R., & Heuvel, C. V. D. (2015). Investigation of the amyloid precursor protein derivative APP96-110 as a novel therapeutic agent following traumatic brain injury. In JOURNAL OF NEUROCHEMISTRY Vol. 134 (pp. 145). Cairns, AUSTRALIA: WILEY-BLACKWELL.
2015 McAteer, K., Corrigan, F., Thornton, E., Turner, R., & Vink, R. (2015). Short and long term behavioral and pathological changes in a novel rodent model of repetitive mild traumatic brain injury. In Abstracts of the 25th Biennial Meeting of the International Society for Neurochemistry jointly with the 13th Meeting of the Asian‐Pacific Society for Neurochemistry in conjunction with the 35th Meeting of the Australasian Neuroscience Society, as published in Vol. 134 (pp. 340-341). Cairns, AUSTRALIA: Wiley-Blackwell.
DOI
2015 Corrigan, F., McAteer, K., & Vink, R. (2015). Toll-like receptor 4 activation exacerbates injury following repetitive mild traumatic brain injury. In JOURNAL OF NEUROCHEMISTRY Vol. 134 (pp. 196-197). Cairns, AUSTRALIA: WILEY-BLACKWELL.
2015 Mander, K., Thornton, E., Harford-Wright, E., Blumbergs, P., & Vink, R. (2015). Characterising tachykinin NK-1 receptor and caveolin-1 expression in cerebral metastases. In JOURNAL OF NEUROCHEMISTRY Vol. 134 (pp. 143-144). Cairns, AUSTRALIA: WILEY-BLACKWELL.
2015 Court-Kowalski, S., Thornton, E., Harford-Wright, E., & Vink, R. (2015). Aquaporin expression correlates with astrocytoma grade and microvascularity. In JOURNAL OF NEUROCHEMISTRY Vol. 134 (pp. 139). Cairns, AUSTRALIA: WILEY-BLACKWELL.
2014 Vink, R. (2014). NEUROPROTECTION: PRECLINICAL/TRANSLATIONAL DISCOVERY. In JOURNAL OF NEUROTRAUMA Vol. 31 (pp. A68-A69). Budapest, HUNGARY: MARY ANN LIEBERT, INC.
2011 Cappai, R., Corrigan, F., Pham, C. L., Vink, R., Masters, C. L., Blumbergs, P. C., & van den Heuvel, C. (2011). DEFINING THE NEUROPROTECTIVE ACTIVITY OF ENDOGENOUSLY EXPRESSED AMYLOID PRECURSOR PROTEIN IN TRAUMATIC BRAIN INJURY. In JOURNAL OF NEUROCHEMISTRY Vol. 118 (pp. 209). WILEY.
2011 Corrigan, F., Pham, C., Vink, R., Masters, C., Blumbergs, P., Cappai, R., & Van den Heuvel, C. (2011). SAPPALPHA RESCUES DEFICITS IN AMYLOID PRECURSOR PROTEIN KNOCKOUT MICE FOLLOWING TRAUMATIC BRAIN INJURY. In JOURNAL OF NEUROTRAUMA Vol. 28 (pp. A67). Shanghai, PEOPLES R CHINA: MARY ANN LIEBERT INC.
2011 Sandoz, B., Anderson, R., Liu, Q., Helps, S., Finnie, J., Blumbergs, P., & Vink, R. (2011). Biomechanical responses in an ovine model of non-accidental head injury (shaken baby syndrome). In Proceedings of the XXIII ISB Congress 2011 (pp. 1-2). online: International Society of Biomechanics.
2011 Sandoz, B., Anderson, R., Finnie, J., Wells, A., Turner, R., & Vink, R. (2011). Reproducible brain injuries produced in a sheep model by direct impact. In Proceedings of The XXIII ISB Congress 2011 (pp. 0 pages). US: International Society of Biomechanics.
2010 Kleinig, T. J., Helps, S. C., Cook, N., Blumbergs, P. C., & Vink, R. (2010). Inhibition of Substance P Reduces Edema and Blood-Brain Barrier Dysfunction Following Rat Collagenase Intracerebral Hemorrhage, but Does Not improve Functional Outcome. In STROKE Vol. 41 (pp. E212-E213). San Antonio, TX: LIPPINCOTT WILLIAMS & WILKINS.
WoS1
2010 Thornton, E., Hassall, M., & Vink, R. (2010). Substance P antagonists reduce onset of experimental L-DOPA induced dyskinesia. In MOVEMENT DISORDERS Vol. 25 (pp. S211-S212). Buenos Aires, ARGENTINA: WILEY-LISS.
2009 Thornton, E., & Vink, R. (2009). Substance P plays a deleterious role in early experimental Parkinson's disease. In MOVEMENT DISORDERS Vol. 24 (pp. S50). Paris, FRANCE: WILEY-LISS.
2009 Cook, N., Van Den Heuvel, C., & Vink, R. (2009). CHARACTERIZATION OF TRPM CHANNEL MESSENGER RNA LEVELS IN TRAUMATIC BRAIN INJURY. In JOURNAL OF NEUROTRAUMA Vol. 26 (pp. A73). Santa Barbara, CA: MARY ANN LIEBERT INC.
2009 Zacest, A. C., Vink, R., Manavis, J., Sarvestani, G. T., & Blumbergs, P. C. (2009). Substance P immunoreactivity increases following human traumatic brain injury. In Acta Neurochirurgica Supplementum (pp. 211-216).
DOI Scopus41
2009 Corrigan, F., Cappai, R., Vink, R., & Van Den Heuvel, C. (2009). DETERMINING THE NEUROPROTECTIVE PROPERTIES OF THE AMYLOID PRECURSOR PROTEIN <i>IN VIVO</i>. In JOURNAL OF NEUROTRAUMA Vol. 26 (pp. A95). Santa Barbara, CA: MARY ANN LIEBERT INC.
2009 Ghabriel, M. N., Zdziarski, I. M., Leigh, C., & Vink, R. (2009). Changes in the blood-CSF barrier in experimental traumatic brain injury. In Acta Neurochirurgica Supplementum (pp. 239-245).
DOI Scopus11
2008 Longstreet, D. A., Heath, D. L., Mar-Shall, E. G., Rolin, S. A., Panaretto, K. S., & Vink, R. (2008). Lower serum magnesium found in indigenous Australians and its implication for type 2 diabetes. In DIABETES Vol. 57 (pp. A103-A104). San Francicso, CA: AMER DIABETES ASSOC.
2007 Thornton, E., & Vink, R. (2007). Chronic Captopril treatment accelerates injury in an early stage rat model of Parkinson's disease. In MOVEMENT DISORDERS Vol. 22 (pp. S230). Istanbul, TURKEY: WILEY-LISS.
2006 Donkin, J. J., Nimmo, A. J., & Vink, R. (2006). Delayed administration of a substance P antagonist at 12H after diffuse traumatic brain injury improves outcome. In JOURNAL OF NEUROTRAUMA Vol. 23 (pp. 778). Rotterdam, NETHERLANDS: MARY ANN LIEBERT INC.
2006 O'Connor, C., Cernak, I., & Vink, R. (2006). The temporal profile of edema formation differs between male and female rats following diffuse traumatic brain injury. In J. Hoff, R. Keep, G. Xi, & Y. Hua (Eds.), Brain edema XIII Vol. 96 (pp. 121-124). New York: Springer.
DOI Scopus49 WoS49 Europe PMC43
2006 Turner, R., Blumbergs, P., Sims, N., Helps, S., Rodgers, K., & Vink, R. (2006). Increased substance P immunoreactivity and edema formation following reversible ischemic stroke. In J. Hoff, R. Keep, G. Xi, & Y. Hua (Eds.), Brain edema XIII Vol. 96 (pp. 263-266). New York: Springer-Verlag.
DOI Scopus44 WoS38 Europe PMC34
2006 Ghabriel, M., Thomas, A., & Vink, R. (2006). Magnesium restores altered aquaporin-4 immunoreactivity following traumatic brain injury to a pre-injury state. In J. Hoff, R. Keep, G. Xi, & Y. Hua (Eds.), Brain edema XIII Vol. 96 (pp. 402-406). Sachsenplatz 4-6 PO Box 89 Vienna Austria A-1201: Springer-Verlag Wien.
DOI Scopus47 WoS38 Europe PMC31
2004 Reardon, K., Heath, D., Nimmo, A., Vink, R., & Whitfield, K. (2004). Inhibition of neurogenic inflammation attenuates the inflammatory response following traumatic brain injury in rats. In 7th International Neurotrauma Symposium, Adelaide, Australia, 12-16 September, 2004 (pp. 115-118). Bologna, Italy: Medimond International Proceedings.
WoS3
2004 Vink, R. (2004). New developments in the pharmacologic management of posttraumatic oedema. In 7th International Neurotrauma Symposium, Adelaide, Australia, 12-16 September, 2004 (pp. 55-60). Bologna, Italy: Medimond International Proceedings.
2004 Donkin, J., Cernak, I., Rodgers, K., & Vink, R. (2004). Mild concussive head injury results in increased brain substance P immunoreactivity. In 7th International Neurotrauma Symposium, Adelaide, Australia, 12-16 September, 2004 (pp. 75-78). Bologna, Italy: Medimond International Proceedings.
WoS2
2004 Van Den Heuvel, C., Thornton, E., Blumbergs, P., Rodgers, K., & Vink, R. (2004). Neuroprotective effects of sAPPα administration following diffuse traumatic brain injury. In 7th International Neurotrauma Symposium, Adelaide, Australia, 12-16 September, 2004 (pp. 145-149). Bologna Italy: Medimond International Proceedings.
2004 Vink, R., O'Connor, C., & Cernak, I. (2004). Both estrogen and progesterone improve functional outcome after diffuse TBI in female and male animals. In JOURNAL OF NEUROTRAUMA Vol. 21 (pp. 1272). San Diego, CA: MARY ANN LIEBERT INC.
2004 Chang, T., Vink, R., Ahmed, F., Cruz, M. I., Zapple, D. N., Faden, A. I., & Cernak, I. (2004). Different bioenergetic responses to injury in immature rodents after diffuse traumatic brain injury. In ANNALS OF NEUROLOGY Vol. 56 (pp. S128-S129). Toronto, CANADA: WILEY-LISS.
2003 Faden, A. I., Movsesyan, V., Stoica, B. A., Knoblach, S. M., Lea, P. M., Ahmed, F., . . . Cernak, I. (2003). The dark side of endocannabinoids: A neurotoxic role for anandamide. In ANNALS OF NEUROLOGY Vol. 54 (pp. S77). SAN FRANCISCO, CALIFORNIA: WILEY-LISS.
WoS1
1999 Cernak, I., & Vink, R. (1999). Magnesium as a regulatory cation in direct and indirect traumatic brain injury. In Z. J. Maksimovic, M. J. Gasic, & M. B. Spasic (Eds.), MAGNESIUM IN THE ENVIRONMENT AND IN ORGANISMS Vol. 92 (pp. 29-38). YUGOSLAVIA, SERBIAN ACAD SCI & ARTS, BELGRADE: SERBIAN ACAD SCIENCES ARTS.
1992 Vink, R. (1992). Nuclear magnetic resonance spectroscopy and the study of tissue oxygen metabolism: A review. In T. K. Goldstick, M. Mccabe, & D. J. Maguire (Eds.), Advances in Experimental Medicine and Biology Vol. 316 (pp. 187-193). TOWNSVILLE, AUSTRALIA: PLENUM PRESS DIV PLENUM PUBLISHING CORP.
DOI Scopus10 WoS13 Europe PMC7
1989 DEMEDIUK, P., FADEN, A. I., VINK, R., ROMHANYI, R., & McINTOSH, T. K. (1989). Effects of Traumatic Brain Injury on Arachidonic Acid Metabolism and Brain Water Content in the Rat. In A. I. BARKAI, & N. G. BAZAN (Eds.), Annals of the New York Academy of Sciences Vol. 559 (pp. 431-432). BETHESDA, MD: NEW YORK ACAD SCIENCES.
DOI Scopus6
1987 MCINTOSH, T., VINK, R., WATSON, J., FERNYAK, S., & FADEN, A. (1987). BENEFICIAL EFFECT OF THE TRH ANALOG CG-3703 ON HYPOTENSION AND NEUROLOGICAL DEFICIT CAUSED BY TRAUMATIC BRAIN INJURY IN RATS. In CIRCULATORY SHOCK Vol. 21 (pp. 376). WILEY-LISS.
1987 FADEN, A. I., KNOBLACH, S., & VINK, R. (1987). METABOLIC CHANGES AFTER EXPERIMENTAL SPINAL-CORD INJURY - ASSESSMENT BY MAGNETIC-RESONANCE SPECTROSCOPY. In ANNALS OF NEUROLOGY Vol. 22 (pp. 118). LITTLE BROWN CO.
1983 VINK, R., BENDALL, M. R., & ROGERS, P. J. (1983). PROTON STOICHIOMETRY OF ATP SYNTHESIS IN ESCHERICHIA-COLI AND REGULATION OF THE ATPASE STUDIED BY P-31-NMR. In PROCEEDINGS OF THE AUSTRALIAN BIOCHEMICAL SOCIETY Vol. 15 (pp. 101). PROC AUST BIOCHEMICAL SOC.

Year Citation
2018 Cappai, R., Inampudi, C., Corrigan, F., Lam, L., Roberts, B., Thornton, E., . . . Van den Heuvel, C. (2018). DELINEATING THE NEUROPROTECTIVE ROLE OF THE AMYLOID PRECURSOR PROTEIN FAMILY IN TRAUMATIC BRAIN INJURY. Poster session presented at the meeting of JOURNAL OF NEUROTRAUMA. Toronto, CANADA: MARY ANN LIEBERT, INC.
2017 Plummer, S. L., Thornton, E., Corrigan, F., Vink, R., Cappai, R., & Van den Heuvel, C. (2017). Evaluating the amyloid precursor protein derivative, APP96-110, as a novel therapeutic agent following traumatic brain injury. Poster session presented at the meeting of JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. Int Soc Cerebral Blood Flow & Metab, Berlin, GERMANY: SAGE PUBLICATIONS INC.
2017 Johnson, I. P., Katharesan, V., Lewis, M., & Vink, R. (2017). Motoneurone loss and age-related inflammatory status. Poster session presented at the meeting of Journal of Anatomy. Sussex: Blackwell Publishing Inc..
2016 Corrigan, F., & Vink, R. (2016). Toll like receptor 4 activation can be either detrimental or beneficial following mild repetitive traumatic brain injury depending on timing of activation. Poster session presented at the meeting of Abstracts of the 12th Symposium of the International Neurotrauma Society, as published in Journal of Neurotrauma. Cape Town, SOUTH AFRICA: Mary Ann Liebert.
DOI
2016 Leonard, A., Menendez, J., Pat, B., Hadley, M., Vink, R., & Floyd, C. (2016). LOCALIZATION OF THE CORTICOSPINAL, RUBROSPINAL AND SPINOTHALAMIC TRACTS IN PIGS: IMPLICATIONS FOR MODELLING TRAUMATIC SPINAL CORD INJURY. Poster session presented at the meeting of JOURNAL OF NEUROTRAUMA. Cape Town, SOUTH AFRICA: MARY ANN LIEBERT, INC.
2014 McAteer, K., Corrigan, F., Thornton, E., van den Heuvel, C., & Vink, R. (2014). CHARACTERISATION OF A NOVEL MODEL OF CHRONIC TRAUMATIC ENCEPHALOPATHY. Poster session presented at the meeting of JOURNAL OF NEUROTRAUMA. Budapest, HUNGARY: MARY ANN LIEBERT, INC.
2014 Plummer, S., Thornton, E., Corrigan, F., Vink, R., Cappai, R., & van den Heuvel, C. (2014). EVALUATING APP96-110, A PEPTIDE DERIVED FROM THE AMYLOID PRECURSOR PROTEIN, AS A NOVEL THERAPEUTIC AGENT AGAINST TRAUMATIC BRAIN INJURY. Poster session presented at the meeting of JOURNAL OF NEUROTRAUMA. Budapest, HUNGARY: MARY ANN LIEBERT, INC.
2013 Leonard, A. V., Thornton, E., & Vink, R. (2013). Raised intrathecal pressure following traumatic spinal cord injury: edema or increased blood volume?. Poster session presented at the meeting of Journal of neurotrauma. USA: Mary Ann Liebert, Inc. Publishers.
2012 Cappai, R., Corrigan, F., Blumbergs, P., Vink, R., & van den Heuvel, C. (2012). Delineating The Neuroprotective Region Of The Amyloid Precursor Protein (APP) Following Traumatic Brain Injury. Poster session presented at the meeting of BRAIN INJURY. INFORMA HEALTHCARE.
2011 Corrigan, F., Vink, R., Masters, C., Blumbergs, P., Cappai, R., & Van Den Heuvel, C. J. (2011). Characterising the effects of amyloid precursor protein knockout on outcome following traumatic brain injury. Poster session presented at the meeting of Journal of neurotrauma. US: Mary Ann Liebert, Inc. Publishers.
2009 Gabrielian, L., Helps, S., Mathias, J., & Vink, R. (2009). Only mass lesions increase intracranial pressure in rats after lateral fluid percussion brain injury and secondary hypoxia. Poster session presented at the meeting of Journal of Neurotrauma. Santa Barbara, California: Mary Ann Liebert.
2008 Wheaton, P., Mathias, J., & Vink, R. (2008). The impact of pharmacological treatments on outcome following traumatic brain injury in adults: A meta-analysis. Poster session presented at the meeting of Brain Injury. Lisbon, Portugal: Informa.

Year Citation
2010 Nimmo, A. J., Whitfield, K. M., Reardon, K., & Vink, R. (2010). US20100311803, Method for reducing inflammatory responses and inflammation.
2010 Vink, R. (2010). US20100184819, Method for reducing intracranial pressure.
2009 Vink, R., & Thornton, E. (2009). WO2009109001, Method for preventing and/or treating a disease, condition or state associated with reduced dopaminergic neuron function.
2008 Nimmo, A. J., Whitfield, K. M., Turner, R. J., & Vink, R. (2008). WO2008067609, Method and composition for reducing reperfusion injury.
2005 Vink, R., & Nimmo, A. (2005). WO/2001/052844, Brain, spinal and nerve injury treatment.. Australia.
2002 Vink, R., & Nimmo, A. J. (2002). EP1261335, Combination of n-acetyl-l-tryptophan and magnesium sulphate for the treatment of brain, spinal and nerve injury.
  • Improving clinical translation in stroke: targeting cerebral oedema in a large animal model, NHMRC - Project Grant, 01/01/2015 - 31/12/2017

Date Role Research Topic Program Degree Type Student Load Student Name
2014 - 2018 Co-Supervisor The Role of Substance P in Chronic Traumatic Encephalopathy Doctor of Philosophy Doctorate Full Time Kelly Marie McAteer
2013 - 2015 Principal Supervisor Characterizing The Role Of Haptoglobin In Experimental Subarachnoid Haemorrhage Master of Philosophy (Medical Science) Master Full Time Mr Thomas Morris
2013 - 2017 Principal Supervisor The Cerebrovascular Response to Metastatic Melanoma and Clostridium Perfringens Type D Epsilon Toxin Doctor of Philosophy Doctorate Full Time Dr Kimberley Anne Mander
2013 - 2017 Co-Supervisor Expression of Substance P and the Tachykinin NK1 Receptor in the Medullary Serotonergic Network of the Human Infant during Development: Implications for Sudden Infant Death Syndrome (SIDS) Doctor of Philosophy Doctorate Full Time Fiona Maree Bright
2012 - 2017 Co-Supervisor Determining if Pre-Existing Inflammation Affects Facial Motoneuronal Survival Doctor of Philosophy Doctorate Full Time Dr Viythia Katharesan
2012 - 2014 Principal Supervisor AQUAPORINS: GATEKEEPERS OF OEDEMA IN TRAUMATIC BRAIN INJURY Doctor of Philosophy Doctorate Full Time Dr Joshua Luke Burton
2012 - 2015 Principal Supervisor Magnesium Polyethylene Glycol: A Novel Therapeutic Agent for Traumatic Brain Injury Master of Medical Science Master Full Time Dr Diana Sabiiti Busingye
2010 - 2014 Principal Supervisor A surgical model of middle cerebral artery occlusive stroke in the sheep Doctor of Philosophy Doctorate Full Time Dr Adam James Wells
2009 - 2010 Principal Supervisor Animal Models for Intracranial Pressure Monitoring in Traumatic Brain Injury Master of Surgery Master Full Time Dr Damian Peter Amato
2009 - 2012 Co-Supervisor The role of Substance P in the Progression and Complications of Secondary Brain Tumours Doctor of Philosophy Doctorate Full Time Miss Kate Marie Lewis
2009 - 2013 Principal Supervisor Characterising the Role of Substance P in Human and Experimental Brain Tumours Doctor of Philosophy Doctorate Full Time Ms Elizabeth Harford-Wright
2009 - 2014 Principal Supervisor The assessment of bullet wound trauma dynamics and the potential role of anatomical models. Doctor of Philosophy Doctorate Part Time Mr Nicholas Russell Maiden
2008 - 2013 Principal Supervisor Development of Novel Pharmacological Treatments for Intracranial Pressure Using Appropriate Experimental Models of Traumatic Brain injury Doctor of Philosophy Doctorate Full Time Mr Levon Gabrielian
2008 - 2011 Co-Supervisor Cellular Pathology and Apoptosis in Experimental and Human Acute and Chronic Compressive Myelopathy Doctor of Philosophy Doctorate Part Time Ms Rowena Newcombe
2008 - 2011 Principal Supervisor The Role of the Amyloid Precursor Protein following Traumatic Brain Injury Doctor of Philosophy Doctorate Full Time APrf Frances Corrigan
2008 - 2012 Principal Supervisor Characterising the Role of Substance P Following Traumatic Spinal Cord Injury Doctor of Philosophy Doctorate Full Time APrf Anna Leonard
2007 - 2010 Principal Supervisor The Role of Substance P in Experimental Intracerebral Haemorrhage Doctor of Philosophy Doctorate Full Time Prof Timothy Kleinig
2007 - 2011 Principal Supervisor Characterising the role of the neuropeptide substance P in experimental subarachnoid haemorrhage Doctor of Philosophy Doctorate Full Time Ms Christine Barry
2006 - 2010 Principal Supervisor Characterisation of Substance P and Transient Receptor Potential Melastatin Channel Messenger RNA and Protein Expression in Acute and Chronic Neurological Disorders Doctor of Philosophy Doctorate Full Time Dr Naomi Cook
2006 - 2011 Co-Supervisor The impact of pharmacological treatments on outcome after adult traumatic brain injury: What does the research show? Doctor of Philosophy Doctorate Full Time Ms Patricia Wheaton
2005 - 2006 Principal Supervisor The Role of Substance P in Cerebral Edema Associated with Rat and Human Infarction and Contusion Master of Medical Science Master Full Time APrf Islam Hassan
2005 - 2009 Principal Supervisor The Role of Substance P in Early Experimental Parkinson's Disease Doctor of Philosophy Doctorate Full Time Dr Emma Thornton
2004 - 2007 Principal Supervisor Characterising the Role of Substance P in Acute Ischaemic Stroke Doctor of Philosophy Doctorate Full Time APrf Renee Turner
2004 - 2008 Principal Supervisor Magnesium and Diabetes: Its Implication for the Health of Indigenous Australians Doctor of Philosophy Doctorate Part Time Ms Diane Alicia Longstreet
2003 - 2004 Principal Supervisor SUBSTANCE P IN TRAUMATIC BRAIN INJURY Master of Surgery Master Full Time APrf Andrew Christian Zacest
2003 - 2006 Principal Supervisor The Effects of the Neuropeptide Substance P on Outcome Following Experimental Traumatic Brain Injury in Rats Doctor of Philosophy Doctorate Full Time Mr James Donkin
2001 - 2004 Principal Supervisor The Effects of Oestrogen and Progesterone on Outcome Following Experimental Traumatic Brain Injury in Rats Doctor of Philosophy Doctorate Full Time Ms Christine OConnor

Connect With Me

External Profiles

Other Links